Novo Nordisk Sheds Stray Assets to Double Down on Obesity Pipeline as Oral Wegovy Gains Traction
Novo Nordisk offloads Parkinson’s cell therapy to focus on obesity and diabetes, with CagriSema pending US approval and…
Berlin’s Long-term Control over Rosneft: A Structural Energy Solution
The European Commission has greenlit a trusteeship structure granting Berlin long-term control over German assets of Russian…